Highlights from BCAN Bladder Cancer Think Tank Meeting 2024

The annual BCAN Bladder Cancer Think Tank Meeting is the premier annual bladder cancer-specific medical meeting in North America.

The Think Tank fosters innovation and collaboration among individuals from the medical, research, and patient communities. Its objective is to accelerate advancements in diagnosing, treating, and enhancing the quality of life for those affected by bladder cancer.

Since its establishment in 2006, the Think Tank meeting has focused on identifying obstacles and creating solutions in bladder cancer research, and has fostered discussions to help define priorities for advancing bladder cancer research.

The invited participants comprise urologists, oncologists, researchers, pathologists, social scientists, patient advocates, and industry representatives, all committed to advancing the diagnosis and treatment of bladder cancer.

Doctors and Professionals shared their highlights from the BCANTT24 meeting on social media: 

Shilpa Gupta, Director of Genitourinary Medical Oncology at Taussig Cancer Institute:

“BCANTT24 Addressing unment needs with ‘Bridging evidence generation to practice in bladder cancer with implementation science’ Food truck analogy by Kristian Stensland.

Amazing panel Andrea Apolo and Thomas Flaig.”

Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington:

“Phenomenal progress in Bladder Cancer in a decade! Multiple stakeholders working together!

Bladder Cancer Advocacy Network, BCANTT24 great session and also talk by brilliant Thomas Flaig on NCCN guidelines.

Great discussion Shilpa Gupta, Laura Bukavina, Omar Alhalabi, Andrea Apolo.”

Tyler Stewart, Genitourinary Oncologist/Researcher at UC San Diego:

“Thanks Bladder Cancer Advocacy Network and Stephanie Chisolm for letting The Adverse Events perform at TT24. Honor and privilege to participate and support this amazing organization and conference. Thanks Petros Grivas for capturing a bit of it.”

Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology:

“BCANTT24 Young Investigator Awardee Rishi Sekar presents data on community-level social drivers and the lack of clinical trial availability. The most vulnerable communities have the lowest access to trials and the highest bladder cancer mortality rates.”

Kathryn Hacker Gessner, Assistant Professor of Urology at University of North Carolina at Chapel Hill:

“Incredible talk by Marc A. Bjurlin on his important work at Urology at UNC on smoking cessation in bladder cancer.”

Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington and Seattle Cancer Care Alliance, shared on X:

“Stellar talk by amazing Andrea Apolo on 1L data in metastatic UC! Huge progress with practice changing data.”

Mary Weinstein Dunn, Associate Professor of Medicine at Northwestern University:

“Proud of my UNC teammates Kathryn Hacker Gessner and Sean Clark-Garvey as they present their important research at BCANTT24. Their ongoing commitment to bladder cancer research will shape the future of patient care. It’s a team effort, with special shout outs to…”

Shilpa Gupta, Director of Genitourinary Medical Oncology at Taussig Cancer Institute:

“Sarah P. Psutka kicks off patient centered clinical research YIA! Amazing leadership by Sarah and Peter Clark for the Bladder Cancer Advocacy Network YIA!”

Laura Bukavina, Urologic Oncologist at Cleveland Clinic:

“Incredible amount of work and dedication went into our Cystectomy book by the whole team including Rebecca Campbell, Nima Almassi, Chris Weight.. it’s the absolute best resource and we are so excited to hopefully share it everyone soon!”

Karine Tawagi, Assistant Professor of Clinical Medicine and Associate Program Director at the University of Illinois:

“2015 vs 2024 National Comprehensive Cancer Network guidelines for Advanced Bladder Cancer Remarkable how far we have come in 10 years as we have improved our treatment options for better patient outcomes in Bladder Cancer.”

For information on more such events, visit oncodaily.com